+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastroenterology Ambulatory Surgery Center Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 115 Pages
  • August 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5616850
The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).

The COVID-19 pandemic seemed to negatively impact the market's growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff-also, prioritizing only the emergency cases negatively impacted the market's growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market's growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.

The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market's growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market's growth.

Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market's growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. In 2019, approximately 60% of the outpatient surgical procedures were performed in ambulatory surgical centers compared to 48% in 2010. Thus due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.

Key Market Trends

The Freestanding Segment is Expected to Hold a Major Market Share in the Gastroenterology Ambulatory Surgery Center Market

The freestanding segment is expected to hold a dominating share in the growth of the market during the forecast period. The freestanding ownership segment, which mainly comprises physician-owned ambulatory surgery centers, is expected to account for the maximum share owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows the physicians to focus on a small number of procedures in a single setting. Endoscopic Ambulatory Service Centers are freestanding facilities designed to carry out gastrointestinal procedures at a low cost. Such beneficial characteristics of the freestanding ownership segment led to the increasing demand for the same among the patients, which allowed the manufacturers to implement various market strategies for market growth. For instance, in 2019, GI Alliance announced its investment in five ambulatory surgery centers owned in part by physicians in its partner practices Texas Digestive Disease Consultants (TDDC) and Illinois Gastroenterology Group (IGG). Thus due to these factors, the studied segment is expected to grow during the forecast period.

North America is Expected to Hold a Significant Share in the Market and is expected to do the Same in the Forecast Period.

The United States is expected to command the global market due to the high incidence of Gastroenterology problems and the high adoption rate of ambulatory surgical centers. For instance, According to the study published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, 60 to 70 million people suffer from gastrointestinal diseases every year in the United States. Additionally, the strong presence of ambulatory surgical centers in the region contributes to the market's growth. For instance, according to the data published by the Medicare Payment Advisory Commission in 2020, the number of active ambulatory surgical centers in the United States is more than 9,280. Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region with dominating share.

Similarly, the innovative product launches to meet the growing demand for gastroenterology ambulatory surgical center services. For instance, in January 2020, Pentax Medical announced that it had received United States Food and Administration (FDA) 510 (K) clearance for its Imagina Endoscopy System, an innovative endoscopy platform for gastrointestinal (GI) procedures at ambulatory surgery centers. Additionally, an increase in research and development activities and favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Gastroenterology Ambulatory Surgery Center Market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some of the companies which are currently dominating the market are Alfa Surgery Center, LLC, Becton, Dickison and Company, Hill- Rom Holdings, GE Healthcare, Koninklijke Philips N.V, Cook Medical, Medtronic, Gastro Health LLC, Ohio Gastroenterology Group Inc, Ontario Advanced Surgery Center, Universal Health Services Inc., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing incidences of gastrointestinal diorders
4.2.2 Rising preferences for ambulatory services
4.3 Market Restraints
4.3.1 Regulatory uncertainaties
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Services
5.1.1 Diagnostic Services
5.1.2 Surgical Services
5.2 By Ownership
5.2.1 Hospital-Affiliated
5.2.2 Freestanding
5.2.3 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Alfa Surgery Center, LLC
6.1.2 Becton, Dickison and company
6.1.3 Hill-Rom Holdings
6.1.4 GE healthacre
6.1.5 Koninklijke PhilipsN.V
6.1.6 Medtronic
6.1.7 Gastro Health LLC
6.1.8 Ohio Gastroeneterology Group Inc
6.1.9 Ontario Advanced Surgery Center
6.1.10 Universal Health Services Inc

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alfa Surgery Center, LLC
  • Becton, Dickison and company
  • Hill-Rom Holdings
  • GE healthacre
  • Koninklijke PhilipsN.V
  • Medtronic
  • Gastro Health LLC
  • Ohio Gastroeneterology Group Inc
  • Ontario Advanced Surgery Center
  • Universal Health Services Inc